APPLICATION OF CELL ENGINEERING TECHNOLOGY TO THE TUMOUR IMMUNOTHERAPEUTIC DRUG: A REVIEW
β Scribed by Z.N. Chen; J.L. Xing; H.J. Bian; L. Mi; J.L. Jiang
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 60 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1065-6995
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In this article, we consider the impact on downstream process design resulting from the use of metabolically engineered yeast strains. We address the issue of how manipulation of cell wall permeability can improve the release and subsequent recovery of heterologous products produced in yeast.
## Abstract The pharmacokinetics of intracellular drugs have recently aroused new interest because monitoring a drug's behaviour near the site of action can enhance knowledge of its efficacy and toxicity. Liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) is particularly attract